Polymyxin B is a Intramuscular; Intrathecal; Intravenous; Ophthalmic Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutic. The primary component is Polymyxin B Sul.
| Product ID | 51991-939_0043d5d0-4e8e-4ad4-9e1a-eedfa4da66fa |
| NDC | 51991-939 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Polymyxin B |
| Generic Name | Polymyxin B |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC |
| Marketing Start Date | 2016-06-01 |
| Marketing End Date | 2019-03-31 |
| Marketing Category | ANDA / |
| Application Number | ANDA207322 |
| Labeler Name | Breckenridge Pharmaceutic |
| Substance Name | POLYMYXIN B SUL |
| Active Ingredient Strength | 500000 1/1 |
| Pharm Classes | Polymyxin-class |
| NDC Exclude Flag | N |
| Marketing Category | ANDA |
| Application Number | ANDA207322 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-04-28 |
| Marketing End Date | 2019-03-31 |
| Marketing Category | ANDA |
| Application Number | ANDA207322 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-06-01 |
| Marketing End Date | 2019-03-31 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9941 | Polymyxin B | Polymyxin B sulfate |
| 39822-0166 | Polymyxin B | Polymyxin B |
| 39822-0170 | Polymyxin B | Polymyxin B |
| 39822-0171 | Polymyxin B | Polymyxin B |
| 45932-0030 | POLYMYXIN B | POLYMYXIN B SULFATE |
| 47781-596 | Polymyxin B | polymyxin B sulfate |
| 51991-939 | Polymyxin B | Polymyxin B |
| 55150-234 | Polymyxin B | Polymyxin B |
| 63323-321 | POLYMYXIN B | POLYMYXIN B SULFATE |
| 63323-367 | POLYMYXIN B | POLYMYXIN B SULFATE |
| 68083-174 | POLYMYXIN B | POLYMYXIN B SULFATE |
| 70594-049 | Polymyxin B | Polymyxin B Sulfate |
| 70860-103 | Polymyxin B | polymyxin B sulfate |
| 70860-124 | Polymyxin B | polymyxin B sulfate |